Dorr M - Search Results

1

A phase I trial of andrographolide in HIV positive patients and normal volunteers.

Calabrese C, Berman SH, Babish JG, Ma X, Shinto L, Dorr M, Wells K, Wenner CA, Standish LJ. Calabrese C, et al. Among authors: dorr m. Phytother Res. 2000 Aug;14(5):333-8. doi: 10.1002/1099-1573(200008)14:5<333::aid-ptr584>3.0.co;2-d. Phytother Res. 2000. PMID: 10925397 Clinical Trial.

2

Audiologic monitoring for potential ototoxicity in a phase I clinical trial of a new glycopeptide antibiotic.

Campbell KC, Kelly E, Targovnik N, Hughes L, Van Saders C, Gottlieb AB, Dorr MB, Leighton A. Campbell KC, et al. Among authors: dorr mb. J Am Acad Audiol. 2003 Apr;14(3):157-68; quiz 170-1. J Am Acad Audiol. 2003. PMID: 12859140 Clinical Trial.

3

Tolerability, pharmacokinetics, and serum bactericidal activity of intravenous dalbavancin in healthy volunteers.

Leighton A, Gottlieb AB, Dorr MB, Jabes D, Mosconi G, VanSaders C, Mroszczak EJ, Campbell KC, Kelly E. Leighton A, et al. Among authors: dorr mb. Antimicrob Agents Chemother. 2004 Mar;48(3):940-5. doi: 10.1128/AAC.48.3.940-945.2004. Antimicrob Agents Chemother. 2004. PMID: 14982787 Free PMC article. Clinical Trial.

4

Human pharmacokinetics and rationale for once-weekly dosing of dalbavancin, a semi-synthetic glycopeptide.

Dorr MB, Jabes D, Cavaleri M, Dowell J, Mosconi G, Malabarba A, White RJ, Henkel TJ. Dorr MB, et al. J Antimicrob Chemother. 2005 Mar;55 Suppl 2:ii25-30. doi: 10.1093/jac/dki008. J Antimicrob Chemother. 2005. PMID: 15750034 Review.

5

Once-weekly dalbavancin versus standard-of-care antimicrobial regimens for treatment of skin and soft-tissue infections.

Seltzer E, Dorr MB, Goldstein BP, Perry M, Dowell JA, Henkel T; Dalbavancin Skin and Soft-Tissue Infection Study Group. Seltzer E, et al. Among authors: dorr mb. Clin Infect Dis. 2003 Nov 15;37(10):1298-303. doi: 10.1086/379015. Epub 2003 Oct 17. Clin Infect Dis. 2003. PMID: 14583862 Clinical Trial.

6

A randomized, double-blind trial investigating the efficacy of caspofungin versus amphotericin B deoxycholate in the treatment of invasive candidiasis in neonates and infants younger than 3 months of age.

Kim J, Nakwa FL, Araujo Motta F, Liu H, Dorr MB, Anderson LJ, Kartsonis N. Kim J, et al. J Antimicrob Chemother. 2020 Jan 1;75(1):215-220. doi: 10.1093/jac/dkz398. J Antimicrob Chemother. 2020. PMID: 31586424 Clinical Trial.

7

Safety profile of sparfloxacin, a new fluoroquinolone antibiotic.

Lipsky BA, Dorr MB, Magner DJ, Talbot GH. Lipsky BA, et al. Among authors: dorr mb. Clin Ther. 1999 Jan;21(1):148-59. doi: 10.1016/S0149-2918(00)88275-2. Clin Ther. 1999. PMID: 10090432

8

Daptomycin for Pediatric Gram-Positive Acute Hematogenous Osteomyelitis.

Bradley JS, Arrieta AC, Digtyar VA, Popejoy MW, Grandhi A, Bokesch P, Hershberger E, Dorr MB, Tan CM, Murata Y, Wolf DJ, Bensaci M. Bradley JS, et al. Among authors: dorr mb. Pediatr Infect Dis J. 2020 Sep;39(9):814-823. doi: 10.1097/INF.0000000000002790. Pediatr Infect Dis J. 2020. PMID: 32639465 Clinical Trial.

9

Effect of Maalox on the oral absorption of sparfloxacin.

Johnson RD, Dorr MB, Talbot GH, Caille G. Johnson RD, et al. Among authors: dorr mb. Clin Ther. 1998 Nov-Dec;20(6):1149-58. doi: 10.1016/s0149-2918(98)80110-0. Clin Ther. 1998. PMID: 9916608 Clinical Trial.

10

Pharmacokinetic interaction of sparfloxacin and digoxin.

Johnson RD, Dorr MB, Hunt TL, Conway S, Talbot GH. Johnson RD, et al. Among authors: dorr mb. Clin Ther. 1999 Feb;21(2):368-79. doi: 10.1016/S0149-2918(00)88293-4. Clin Ther. 1999. PMID: 10211539 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

689 results

Search Page